KARYOPHARM THERAP.DL-0001 earnings per share and revenue

25K earnings per share for the last quarter are -0.23 EUR whereas the estimation was -0.24 EUR which accounts for 1.09% surprise. Company revenue for the same period amounts to 34.83 M EUR despite the estimated figure of 34.06 M EUR. Estimated earnings per share for the next quarter are -0.23 EUR, and revenue is expected to reach 35.97 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.